Article | REF: BIO6255 V1

Polyhydroxyalkanoates for Biomedical Applications

Authors: Jean GUEZENNEC, Yves-Marie CORRE, Christelle SIMON-COLIN

Publication date: November 10, 2014, Review date: May 16, 2024

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


Overview

Français

ABSTRACT

Polyhydroxyalkanoates (PHAs) belong to a class of bioderived polyesters. They are produced by a large number of microorganisms for energy storage purposes. Through the use of different carbon substrates, culture conditions and careful selection of bacterial species a large variety of such biopolymers can be reached. Due to specific properties such as biodegradability and biocompatibility PHA are expected to find applications in biomedical area in the near future. Due to its large and still unknown biodiversity, marine environment suggested itself as a source of novel PHA producing microorganisms.

Read this article from a comprehensive knowledge base, updated and supplemented with articles reviewed by scientific committees.

Read the article

AUTHORS

  • Jean GUEZENNEC: Scientific consultant Plouzané (France), AiMB (Advices in Marine Biotechnology)

  • Yves-Marie CORRE: Research engineer, Materials Engineering Laboratory of Brittany (LIMATB) University of Southern Brittany Lorient (France)

  • Christelle SIMON-COLIN: Biochemist, Ifremer, UMR 6197, Laboratory of Microbiology of Extreme Environments, Technopôle Brest-Iroise, UBO, CNRS, Plouzané (France)

 INTRODUCTION

Polyhydroxyalkanoates (PHAs) are biopolymers synthesized by bacteria in response to unfavorable environmental conditions. These biodegradable polymers offer an alternative to synthetic polymers derived from petrochemicals. Numerous applications are expected, given the possibility of upstream control of the nature of these polymers through actions on culture and fermentation conditions, the carbon source and, of course, the producing strains. Their biodegradability and biocompatibility, their mechanical properties, and the fact that they can be combined with other molecules or polymers in a variety of ways, also favour applications in most healthcare fields (hematology, cardiology, ophthalmology, dermatology, tissue and bone regeneration, etc.). Studies have yet to be carried out, notably on oligomers and functionalized polymers, but many parameters point to the imminent development of these biopolymers in this field. All this, however, does not exclude the interest that can also be generated by the search for and identification of new production strains. In this respect, the marine environment, with its little-known and little-exploited microbial biodiversity, is a potential source of new microorganisms capable of producing new PHAs under controlled conditions.

You do not have access to this resource.

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


The Ultimate Scientific and Technical Reference

A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
+ More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects

This article is included in

Bioprocesses and bioproductions

This offer includes:

Knowledge Base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

Practical Path

Operational and didactic, to guarantee the acquisition of transversal skills

Doc & Quiz

Interactive articles with quizzes, for constructive reading

Subscribe now!

Ongoing reading
Polyhydroxyalkanoates (PHA): healthcare applications